PAYER POLICY CHANGES

61790 Insurance Policy Changes

CPT 61790, in plain terms, covers Percutaneous stereotactic lesion of the gasserian ganglion using a neurolytic agent such as alcohol, thermal, electrical, or radiofrequency energy. CPT 61790 is referenced in 1 tracked payer policy change from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 61790 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Official descriptor: CPT 61790 on AAPC

Watch 61790

Get one email when a payer policy names 61790, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

See every payer rule for 61790

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for 61790 in one place.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.